@article{ba318e214673407e830dd7ff3dce7d3f,
title = "WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30–80-cm3 and 80–150-cm3 Prostates",
abstract = "Comparing data from WATER and WATER II trials, we found that Aquablation is effective in patients with a prostate of 30–80 cm3 and patients with a prostate of 80–150 cm3 treated for lower urinary tract symptoms due to benign prostatic hyperplasia, with comparable outcomes in both groups. Functional outcome improvements are durable and retreatment rates are low at 2 yr of follow-up.",
keywords = "Aquablation, Benign prostatic hyperplasia, Robotics",
author = "Nguyen, {David Dan} and Neil Barber and Mo Bidair and Peter Gilling and Paul Anderson and Zorn, {Kevin C.} and Gopal Badlani and Mitch Humphreys and Steven Kaplan and Ronald Kaufman and Alan So and Ryan Paterson and Larry Goldenberg and Dean Elterman and Mihir Desai and Jim Lingeman and Claus Roehrborn and Naeem Bhojani",
note = "Publisher Copyright: {\textcopyright} 2021 Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2021",
month = mar,
doi = "10.1016/j.euros.2021.01.004",
language = "English (US)",
volume = "25",
pages = "21--28",
journal = "European Urology Open Science",
issn = "2666-1691",
publisher = "Elsevier BV",
}